IJSR International Journal of Scientific Research 2277 - 8179 Indian Society for Health and Advanced Research ijsr-6-1-9907 Original Research Paper Dyslipidemia in infancy – Is screening the way forward? Parimala V Thirumalesh Dr. January 2017 6 1 01 02 ABSTRACT

 Dyslipidemias are disorders of lipoprotein metabolism resulting in elevated levels of cholesterol, triglycerides, low density lipoproteins and decreased or normal high density lipoproteins. These disorders are often asymptomatic and lead to atherosclerosis and early death if undetected. The prevalence is reported to be as high as 20 percent in children between the age of six and nineteen years in the United States where routine screening is in practice. The prevalence in our country and in the age group below six years universally is unknown

In this case report the authors describe a 5 month old infant who presented with gastroenteritis and was detected to have dyslipidemia incidentally due to his lipemic blood sample. Since the mainstay of treatment is dietary management, introducing it early on during the weaning period and avoiding the usual practice of high fat diet for weaning will prove to be a key factor in lowering the risk of morbidity and mortality in these children. This article aims to raise the question of whether screening for dyslipidemia should begin before the weaning age universally so that proper dietary management can be initiated early on to prevent morbidity and mortality in these silent sufferers.